Alzevita
Overview
Alzevita is a cutting-edge, cloud-based AI-powered medical image processing software designed to assist neurologists, radiologists, and imaging labs in the analysis of 3D brain MRI scans. The tool automates hippocampal segmentation and volumetric reporting, providing consistent, quantifiable results from brain MRI scans. This supports objective reporting and helps streamline clinical workflows, enhancing speed, reproducibility, and confidence in neuroimaging.
Alzevita leverages state-of-the-art deep learning techniques, including UNet++ Architecture, ResNet Backbone, and Split Attention Mechanism, to deliver precise segmentation and volumetric analysis of the hippocampus. This innovation is designed to significantly enhance early diagnosis and monitoring of neurodegenerative conditions, such as Alzheimer’s disease, by identifying and quantifying changes in hippocampal structure. It supports industry-standard imaging formats like DICOM and NIFTI, making it interoperable and easy to integrate into existing radiology infrastructures.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-Based Hippocampal Segmentation
- Quantitative Volumetric Analysis of Brain Structures
- High Reproducibility and Standardization of Outputs
- Supports Industry-Standard Imaging Formats (DICOM, NIFTI)
- Cloud-Based Deployment
- Assists Neurologists and Radiologists in Diagnosis
- Supports Objective Reporting
- Streamlines Clinical Workflows
- Enhances Diagnostic Confidence
- Utilizes Advanced Deep Learning Techniques (UNet++, ResNet, Split Attention)
Use Cases
- Early diagnosis and monitoring of Alzheimer's Disease
- Assessment of neurodegenerative conditions
- Automated brain MRI analysis for radiologists and imaging labs
- Evaluating structural brain changes over time
- Integration into clinical and research settings
- Replacing manual hippocampal segmentation workflows
What Physicians Need to Know
Alzevita is designed to be a supportive tool for neurologists, radiologists, and researchers, providing quantitative and reproducible data from brain MRI scans. It automates the time-consuming task of hippocampal segmentation, allowing for more efficient workflows and consistent results. Physicians can leverage the volumetric reports, normative comparisons, and longitudinal tracking features to gain objective insights into brain structural changes, which can aid in the early assessment and monitoring of neurodegenerative conditions like Alzheimer's disease. It's important to remember that Alzevita is a clinical decision support tool and does not replace clinical interpretation, diagnosis, or treatment decisions, which should always be made by qualified healthcare professionals.
Alzevita currently operates as a cloud-based system. PACS integration is under development, with future plans to include cloud-based workflows, PACS-integrated transfer and storage, and report access via PACS. The platform supports industry-standard imaging formats, including DICOM and NIFTI, facilitating its integration into existing radiology infrastructure and DICOM workflows.
Details
| Category | Neurology AI, Radiology & Imaging AI |
| Pricing | Contact vendor for pricing |
| Deployment | Cloud |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Radiology |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2025-12-19 | K252670 510(k) | Alzevita |
Ratings & Reviews
No reviews yet. Be the first to review this tool!





